{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:05:08Z","timestamp":1790885108254,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.metabol.2009.09.018","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T08:37:33Z","timestamp":1258533453000},"page":"734-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans"],"prefix":"10.1016","volume":"59","author":[{"given":"Marica","family":"Bordicchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Battistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mancinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Refi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Minardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Muzzonigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mazzucchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Dess\u00ec-Fulgheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Sarzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2009.09.018_bib1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"Poirier","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2009.09.018_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/HJH.0b013e3282f624a0","article-title":"Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome and hypertension: an integrated view in humans","volume":"26","author":"Sarzani","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2009.09.018_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.ijo.0802213","article-title":"Obesity and target organ damage: the kidney","volume":"26","author":"de Jong","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2009.09.018_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.ackd.2004.10.014","article-title":"The influence of obesity on the development and survival outcomes of chronic kidney disease","volume":"12","author":"Wiggins","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.metabol.2009.09.018_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2009.09.018_bib6","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the peripheral endocannabinoid system in human obesity","volume":"54","author":"Engeli","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2009.09.018_bib7","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db06-0812","article-title":"Dysregulation of the peripheral and adipose tissue endocannabinoid system inhuman abdominal obesity","volume":"55","author":"Bluher","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2009.09.018_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","article-title":"Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men","volume":"31","author":"Cote'","year":"2007","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2009.09.018_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00125-008-1178-6","article-title":"Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with 365 changes in metabolic risk factors","volume":"52","author":"Di Marzo","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2009.09.018_bib10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s00125-008-1048-2","article-title":"The endocannabinoid system in obesity and type 2 diabetes","volume":"51","author":"Di Marzo","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2009.09.018_bib11","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despres","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2009.09.018_bib12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2009.09.018_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2009.09.018_bib14","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","article-title":"Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomized controlled study","volume":"368","author":"Scheen","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2009.09.018_bib15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/dc05-1801","article-title":"Measurement of the high\u2013molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome","volume":"29","author":"Hara","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2009.09.018_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/sj.mp.4001560","article-title":"Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse","volume":"9","author":"Zhang","year":"2004","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.metabol.2009.09.018_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ymgme.2007.01.002","article-title":"No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents","volume":"90","author":"M\u00fcller","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2009.09.018_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ymgme.2008.07.008","article-title":"Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes","volume":"95","author":"Aberle","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2009.09.018_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12020-007-0022-y","article-title":"The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men","volume":"31","author":"Peeters","year":"2007","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2009.09.018_bib20","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/jc.2006-2523","article-title":"Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men","volume":"92","author":"Russo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.09.018_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/381000","article-title":"Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium","volume":"74","author":"Carlson","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2009.09.018_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.metabol.2008.10.009","article-title":"Altered pattern of cannabinoid CB1 receptor expression in adipose tissue of dysmetabolic and overweight patients","volume":"58","author":"Sarzani","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2009.09.018_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/01.HYP.19.6.702","article-title":"Local renin-angiotensin system in human adrenals and aldosteronomas","volume":"19","author":"Sarzani","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2009.09.018_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2009.09.018_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/jhh.2008.8","article-title":"TCF7L2 alleles and metabolic syndrome in non-diabetic obese hypertensive patients","volume":"22","author":"Sarzani","year":"2008","journal-title":"J Hum Hypertens"},{"issue":"286","key":"10.1016\/j.metabol.2009.09.018_bib26","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.mce.2008.01.026","article-title":"Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets","volume":"16","author":"Matias","year":"2008","journal-title":"Mol Cell Endocrinol."},{"key":"10.1016\/j.metabol.2009.09.018_bib27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.ki.5002540","article-title":"Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats","volume":"72","author":"Janiak","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2009.09.018_bib28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1681\/ASN.2005060638","article-title":"Obesity and risk for chronic renal failure","volume":"17","author":"Ejerblad","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2009.09.018_bib29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1300695","article-title":"Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.metabol.2009.09.018_bib30","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.09.018_bib31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/ijo.2008.105","article-title":"Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant","volume":"32","author":"Herling","year":"2008","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2009.09.018_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/ATVBAHA.108.176362","article-title":"ADAGIO-Lipids Investigators. Effect of rimonabant on the high-triglyceride\/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial","volume":"29","author":"Despr\u00e9s","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2009.09.018_bib33","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1074\/jbc.270.8.3726","article-title":"An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing","volume":"270","author":"Shire","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2009.09.018_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0079-6603(02)72069-2","article-title":"Regulation of pathways of mRNA destabilization and stabilization","volume":"72","author":"Dodson","year":"2002","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1016\/j.metabol.2009.09.018_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004872-199816010-00014","article-title":"Gene expression of the renin angiotensin system in human kidney","volume":"16","author":"Lai","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2009.09.018_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.ijo.0801086","article-title":"Visceral fat loss evaluated by total body magnetic resonance imaging in obese women operated with laparascopic adjustable silicone gastric banding","volume":"24","author":"Busetto","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2009.09.018_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/oby.2003.3","article-title":"Adipose tissue quantification by imaging methods: a proposed classification","volume":"11","author":"Shen","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.metabol.2009.09.018_bib38","first-page":"291","article-title":"The regulation of adipose tissue distribution in humans 1996","volume":"20","author":"Bj\u00f6rntorp","year":"1996","journal-title":"Int J Obes Relat Metab Disord"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509004089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509004089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:43:06Z","timestamp":1758426186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049509004089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0026049509004089"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2009.09.018","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2009.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}